Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma

NCT04309084 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

29

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma
Neoplasm, Plasma Cell
Neoplasms by Histologic Type
Neoplasms
Hemostatic Disorder
Vascular Diseases
Cardiovascular Diseases
Paraproteinemias
Blood Protein Disorders
Hematologic Diseases
Hemorrhagic Disorders
Lymphoproliferative Disorders
Immunoproliferative Disorders
Immune System Diseases
Antineoplastic Agents
Analgesics, Non-Narcotic
Analgesics
Sensory System Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs

Interventions

BIOLOGICAL: CYNK-001

Sponsor

Celularity Incorporated